Редактирование:
KCNQ3
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3) ==Publications== {{medline-entry |title=Age-dependent modulation of hippocampal excitability by KCNQ-channels. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/12576170 |abstract=Recently, mutations of [[KCNQ2]] or [[KCNQ3]], members of the KCNQ-related K( )-channel (KCNQ-channel) family, were identified as cause of benign familial neonatal convulsions (BFNC). However, the exact pathogenic mechanisms of age-dependent development and spontaneous remission of BFNC remain to be elucidated. To clarify the age-dependent etiology of BFNC, we determined age-dependent functional switching of KCNQ-channels, GABAergic- and glutamatergic-transmission in rat hippocampus. The effects of inhibitors of KCNQ-channel, GABA- and glutamate-receptors on propagation of neuronal-excitability and neurotransmitter release were determined by 64-channel multielectrode-dish (MED64), whole-cell recording, in vitro release technique and in vivo microdialysis biosensor, using rat hippocampus from day of birth (P0) to postnatal-day 56 (P56). Inhibition of KCNQ-channels enhanced depolarization-induced glutamate and GABA releases during P0-P7, but not during P14-P28. Inhibition of KCNQ-channels magnified neuronal-excitability propagation from P0 to P14: maximal at P3, but this effect disappeared by P28. GABA(A)-receptor inhibition surprisingly reduced neuronal-excitability propagation during P0-P3, but not at P7. AMPA/glutamate-receptors inhibition reduced propagation of neuronal-excitability throughout the study period. KCNQ-channels inhibition shortened spike-frequency adaptation, but this stimulation was more predominant during P<7 than P>14. During the first week of life, KCNQ-channels performed as a predominant inhibitory system, whereas after this period GABAergic-transmission switched from excitatory to inhibitory function. Contrary, glutamatergic-transmission has acquired as excitatory function from P0. These findings suggest that the pathogenic mechanisms of age-dependent development and spontaneous remission of BFNC are, at least partially, associated with the interaction between age-dependent reduction of inhibitory KCNQ-channel activity and age-dependent functional switching of the GABAergic-system from excitatory to inhibitory action in neonatal CNS. |mesh-terms=* Aging * Animals * Biosensing Techniques * Cortical Spreading Depression * Epilepsy, Benign Neonatal * Glutamic Acid * Hippocampus * Male * Membrane Potentials * Microdialysis * Neurons * Neurotransmitter Agents * Potassium * Potassium Channels * Rats * Rats, Wistar * Remission, Spontaneous * Synaptic Transmission * gamma-Aminobutyric Acid |full-text-url=https://sci-hub.do/10.1016/s0920-1211(02)00249-8 }} {{medline-entry |title=The [[KCNQ2]] potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with [[KCNQ3]]. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/9827540 |abstract=Benign familial neonatal convulsions, an autosomal dominant epilepsy of newborns, are linked to mutations affecting two six-transmembrane potassium channels, [[KCNQ2]] and [[KCNQ3]]. We isolated four splice variants of [[KCNQ2]] in human brain. Two forms generate, after transient expression in COS cells, a potassium-selective current similar to the [[KCNQ1]] current. L-735,821, a benzodiazepine molecule which inhibits the [[KCNQ1]] channel activity (EC50 = 0.08 microM), also blocks [[KCNQ2]] currents (EC50 = 1.5 microM). Using in situ hybridization, [[KCNQ2]] and [[KCNQ3]] have been localized within the central nervous system, in which they are expressed in the same areas, mainly in the hippocampus, the neocortex and the cerebellar cortex. During brain development, [[KCNQ3]] is expressed later than [[KCNQ2]]. |mesh-terms=* Aging * Alternative Splicing * Amino Acid Sequence * Animals * Benzodiazepines * Brain * COS Cells * Gene Expression Regulation * Gene Expression Regulation, Developmental * Genetic Variation * Humans * In Situ Hybridization * KCNQ2 Potassium Channel * KCNQ3 Potassium Channel * Mice * Molecular Sequence Data * Organ Specificity * Potassium Channels * Potassium Channels, Voltage-Gated * RNA, Messenger * Recombinant Proteins * Transcription, Genetic * Transfection |full-text-url=https://sci-hub.do/10.1016/s0014-5793(98)01296-4 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup